Member Info for Scoobydoo321

Rare Earths - the Wall Street Journal cottoning on.
Can only be good for the REM mining.

https://www.wsj.com/video/tech-companies-depend-on-china-for-rare-earths-can-that-change/674228C1-D75A-4598-8597-D68108CDA45F.html

Cheers Nick - thought they put the CARMA programme on hold tho?

From BRES' twitter feed -
Latest broker comment from
@FirstEquityLtd
:
"With these thoughts in mind, we believe the market cap should currently be in the region of at least £25m, which would equate to a share price of 21.1p or more."

Direct from MKA's twitter feed -
https://twitter.com/EdConwaySky/status/1388484300027408384
and
https://www.birmingham.ac.uk/documents/college-eps/energy/policy/policy-comission-securing-technology-critical-metals-for-britain.pdf

It's getting hotter out there ....

@Jones - I was wondering whether there would be a connection to MXCT after reading this article - what is the connection Jones?

It's the magic of the PR media agency in Silicon Valley - probably paying $$$ for it - but hey - if it's getting in prospects - it's working the magic! I reckon their pipeline must be bottlenecked with enquiries!

It's been around on utube for a few yrs - but still an intriguing watch - reminds us of the importance of RE's
https://www.youtube.com/watch?v=88jpgxSRVZU

https://www.share-talk.com/yoav-keren-ceo-brandshield-systems-brsd-l-interview/?utm_content=164832363&utm_medium=social&utm_source=twitter&hss_channel=tw-1685619204#gs.zp1uhy

@Munchbox
JGI's appointment to advise MKA on strategy in the USA is not a pump.
Bacchus Capital's appointment as adviser is not a pump.
Rare Earth's increasing prices are not a pump.

As a shareholder, I am delighted that MKA's potential is being recognized at last. So why seek to squeeze the air out of the bag ? We all know that MKA is substantially undervalued.

@CMEU - the trials are taking place in Israel and Brazil.
https://www.proactiveinvestors.co.uk/companies/news/944472/mgc-pharmaceuticals-gains-7-on-approval-for-phase-iii-trial-of-cimetra-944472.html
I believe prelim results out by this quarter to end of June.

Research notes latest
https://www.edisongroup.com/publication/up-for-it/29422

In an inflationary environment - being in commodities is a pretty good idea.

I've been surprised by the SP action and response to latest TU. The seller must have been the reason for the lacklustre action. Seller appears to be out, now just needs more momentum with volume.

@LeM - have you gone nuts?
:)

If and only if (and no reason to doubt given outstanding success of phase 2 trials), phase 3 meets all the end points - their drug could be a game changer for WHO Covid Taskforce. A very exciting period they are going through.

Their new platform has incredible potential - to make brands aware of fakes / imposter websites.

Fantastic marketing initiative which will undoubtedly drive up prospective client enquiries.

@Chris5
Last two years H1 TU
17 Jul 2019
15 Jul 2020

Some laxatives required pls !

27-Apr-21 16:41:56 69.00 50,000 Sell* 69.00 70.00 34.50k O
27-Apr-21 10:34:19 69.00 200,000 Sell* 69.00 70.00 138.00k O
27-Apr-21 10:23:13 69.00 200,000 Sell* 69.00 70.00 138.00k O
27-Apr-21 09:50:07 69.00 100,000 Sell* 69.00 70.00 69.00k O

That's some serious constipation - now that is out of the way - hopefully SP can now proceed north.
27-Apr-21 14:51:12 22.50 1,500,000 Sell* 22.00 24.00 337.50k

This Confucius saying is more appropriate for LEX - “The man who moves a mountain begins by carrying away small stones.”

Now gimme the moneeee

Company has been far too low key to date.
Tremendous potential.